Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization | JACC: Advances
de
JACC Specialty Journals
2025-09-24 18:00:00
Fecha de lanzamiento
03:02
Duración
